In an effort explore the feasibility of a baculovirus recombinant dengue-1 (DEN 1) virus vaccine, a portion of the envelope (E) glycoprotein gene from DEN 1 virus was cloned and expressed in baculovirus (IAutographa californical nuclear polyhedrosis virus, AcNPV). The recombinant construct contains 107 nucleotides from the 3' terminus of the M gene which encodes a hydrophobic signal peptide and extends through the first 1245 nucleotides of E, terminating 243 nucleotides before the 3' terminus of E.
When the recombinant was grown in ISpodoptera frugiperdal cells, about 1 mg of E antigen was made per 10\9/ cells. The recombinant E antigen reacted with E protein-specific monoclonal antibodies and stimulated the production of DEN 1 virus neutralizing antibody in BALB/c mice.
Mice immunized with the recombinant E antigen or with heat-inactivated DEN 1 virus were protected significantly against lethal DEN 1 virus challenge.
A dose response effect was observed with increasing amounts of recombinant antigen leading to increased survival.
14. These results demonstrate the utility of baculovirus for 'producing immunogens against DEN 1 virus. DENGUE 
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Abstract. In order to test the feasibility of baculovirus (Autographa calilorntca nuclear polyhedrosis virus, AcNPV) expression vectors for making immunogens against dengue-I (DEN-I) virus, a portion of the envelope (E) glycoprotein gene of DEN-I virus was cloned and expressed. The recombinant baculovirus contains 107 nucleotides from the 3' terminus of the DEN-I matrix (M) gene. which encodes a hydrophobic signal peptide and extends through the first 1. 245 nucleotides of E. terminating 243 nucleotides before the 3' terminus of E. When the recombinant virus was grown in Spodoptera frugiperda cells. about I mg of E antigen was made per 10' cells. Recombinant E antigen reacted with E protein-specific monoclonal antibodies and stimulated production of DEN-I virus neutralizing antibody in BALB/c mice. Mice immunized with recombinant E antigen or with heat-inactivated DEN-1 virus were protected significantly against lethal DEN-I virus challenge. A dose/response effect was observed, with increasing amounts of recombinant antigen leading to increased survival. These results demonstrate the utility of baculovirus for producing immunogens against DEN-I virus.
Dengue-I (DEN-1) virus is one of four seroface protein of the Ilavivirion: it functions in cell types (DEN-i. DEN-2. DEN-3. and DEN-4) of attachment and contains neutralization epitopes the dengue virus group in the family flaviviridae. I thought to be important in antiviral immuniThe virus, which is transmitted by Aedes aet'ypti ty.:-'-The E protein is preceded in the polymosquitoes. generally causes an acute, febrile ill-protein by a hydrophobic amino acid segment at ness.-However. more serious illnesses, dengue the carboxyl-terminus of prM/M that functions hemorrhagic fever, and shock syndrome, can also as a cleavable transmembrane sequence.' It teroccur.
• Thus far, no effective vaccines against minates with two hydrophobic segments at the dengue viruses have been licensed for human carboxyl-terminus. which may serve as a memuse. although several live attenuated vaccines brane anchor.' -" have been used experimentally in man with varyKnowledge of flavivirus gene structure. couing success.-7 pled with positive results obtained with authenDengue is an enveloped, positive-stranded, tic E and NS I proteins as subunit immunogens RNA virus about 50 nanometers in diameter.? in animal models: 8 . " has led to the use of reLike the prototype flavivirus yellow fever, all combinant cDNA technology for producing these of its viral proteins are encoded by a single. long, proteins. Baculovirus vectors have attracted open-reading frame of about 10.5 kilobases ar-much interest because of the potentially high levranged as follows: 5' C-prM/M-E-NSI-NS2A-els of foreign gene expression that can be at-NS2B-NS3-NS4A-NS4B-NS5 3'.10-i5 Virion tained," and for their lack of pathogenicity for structural proteins (capsid. pre-matrix/matrix and humans. Foreign genes are expressed from the envelope) are encoded at the 5' end, followed by baculovirus polyhedrin promotor.
3 12 and renonstructural (NS) proteins encoded by the re-combinant proteins appear to be correctly promainder of the genome. Proteins are produced cessed and glycosylated.'--" by co-translational proteolytic processing by host Baculovirus has been used for expression of cell signal peptidasel 6 -2 0 and putative viral pro-flaviviruses, including DEN-4. in which a polyteinases.'• 2 2 genic region, C-prM-E-NSI-NS2A. yielded anThe envelooe (E) ulvcoorotein is the major sur-tigens that conferred complete protection to 159
93-00673
.p I qWRPTHW 1, 063 mice, 3 1 and Japanese encephalitis (JE), in which cific antiserum (mouse hyperimmune ascitic flupolygenicregions, C-prM-E, prM-E-NSI-NS2A-id. MHAF. 1:200) against DEN-., followed by NS2B. or E by itself, yielded antigens that elicited goat anti-mouse immunoglobulin (instead of neutralizing antibody4. 36 and protected mice.31 protein A used in the original method) labeled These results point to flavivirus E protein made with 121I (106 cpm/ml).
by baculovirus as a potential recombinant immunogen.
Heat-inactivation of DEN-I virus We report herein that an E gene cDNA sequence derived from DEN-1, when expressed in DEN-I virus from infected C6/36 mosquito baculovirus, synthesized protein that was anti-cell culture supernates (approximately 4 x 10" genic, elicited DEN-I virus-neutralizing anti-PFU/ml in Eagle's minimal essential medium body in mice, and provided significant protec-with 2% bovine serum albumin) was heated at tion against mortality from DEN-I encephalitis. To prepare recombinant antigen for mouse tion of a recombinant E gene fragment by diges-immunization, S. frugiperda cells infected with tion with BstNI (cuts at nucleotides 801 and recombinant baculovirus were pelleted. lysed by 2150). The restriction fragment was treated with Dounce homogenization, nuclei were removed bacteriophage T4 DNA polymerase and all four by centrifugation at 1,000 x g. and the microdeoxynucleoside triphosphates to make blunt somal membrane fraction containing E antigen ends, and cloned into the unique Sinai site of a was pelleted at 100,000 x g for I hr. and resusbaculovirus (Autographa californica nuclear pended in phosphate-buffered saline (PBS) (crude polyhedrosis virus, AcNPV) recombination vecmembrane preparation). Three-week-old BALB/ tor, pAcMGS. described previously. 34 Recom-c mice (Charles River. Wilmington, MA) were binant baculovirus was obtained by co-transimmunized by intraperitoneal (ip) injection with fecting S. frugiperda insect cells in monolayer 0.1 ml of crude membrane preparation containculture with the recombination vector and wildi typebaclovius NA. s aresut o homlo-ing recombinant E antigen in PBS. pH 7.4. and type baculovirus DNA. As a result of homoiointramuscular (im) injection with 0.1 ml of the gous recombination, the baculovirus polyhedrin same preparation in Freund's complete adjuvant gene was replaced by the DEN-I cDNA insert. (1: 1 v/v) (first dose, day I) and Freund's incomrendering recombinants polyhedrin negative." plete adjuvant (second dose, day 3. third dose. Viruses forming polyhedrin occlusion body-day 28. and fourth dose, day 30). Approximately negative (clear) plaques were selected and plaque-4 ug of E antigen was given in each dose. One purified three times. Recombinant virus was used day after the fourth dose. ascitic fluid formation to infect S. frugiperda cells in suspension cul-was induced by ip injection of 5 x 106 sarcoma tures. Infected cells were pelleted by low speed 180 cells and fluids harvested from the peritoneal centrifugation and lysed by Dounce homogeni-cavity about 12 days later with an 18 gauge neezation. Cell lysates were electrophoresed on poly-die. 4 , acrylamide gels containing sodium dodecylsulfate (SDS), 3 ' and either stained with Coomassie Mouse protection assay blue R-250 or electrophoretically transferred to nitrocellulose. Antigenic bands were detected by
The BALB/c mice were immunized beginning a modification of Western blotting, 3 9 using spe-at three weeks of age by ip and im injection with 0.1 ml of crude cell membrane preparation con-by staining on day 7 with 0.05% neutral red in taining varying amounts of recombinant E an-normal saline. Titers reported are the reciprocal tigen. an equivalent amount of membrane prep-dilutions of antisera that inhibited the number aration without E antigen (negative control). or of virus plaques by Ž-50%. compared with sera 0.1 ml of heat-inactivated DEN-I virus (ap-from mice immunized with PBS or with uninproximately 4 x 106 PFU/ml before inactiva-fected S. ftugiperda cells. Titers _ 10 were contion; positive control). Injections were given ip sidered positive. without adjuvant and im in Freund's complete adjuvant (1: 1 v, v) (first dose, day 1) and Freund's Statistical anal/sis incomplete adjuvant (second dose, day 3. third dose, day 14). Mice were challenged on day 21 Data were tested for significance using a Chi-(at six weeks of age) with a lethal dose of Western square test. Fisher's exact test, or linear regresPacific strain (Nauru Island 1974) DEN-I virus sion analysis, as appropriate.
(50 gl of a 1: 100 dilution of virus-infected suckling mouse brain suspension, approximately 10' PFU, 100 LD,,) administered intracranially (ic).
RESULTS
At each day post-challenge, the mice were ob-.lntgentciti and tieldotfrecombinantproteintrom served for morbidity and mortality.
taculot-irus-inlected S. frugiperda cells with the same molecular weight was not seen with recombinant-infected cells, indicating a Virus plaque-reduction neutralization (PRNT-lower than expected level of expression. The 50%) assay amount of recombinant antigen was estimated to be about I mg per 101 cells by comparing. on Plaque reduction neutralization assays were a Western blot, the recombinant-infected cell lydone essentially as previously described. 4 ' with sate with highly purified recombinant E protein ascites or sera from immunized mice and West-of known concentration (unpublished data). ern Pacific (Nauru Island I Q74) DEN-I virus.
Radio-immunoblot assay
In order to demonstrate specificity, the recomMonkey kidney (LLC-MK2) cell monolayers in binant antigen was reacted with several mono-6-well plates (Costar, Cambridge, MA) were used. clonal antibodies, including ones specific for the Plates were incubated in sealed plastic bags at E protein of DEN-1. Positive reactions were seen 36*C in a CO, incubator. Plaques were visualized with anti-E, but not anti-NS I monoclonal anti- Table 1) . These results confirmed that three-week-old BALBic mice was immunized the recombinant antigen was a specific product with a crude membrane preparation from recomof the cloned DEN-I E gene.
binant baculovirus-infected S. trugiperda cells The recombinant antigen was found to be in-containing DEN-I E antigen (three doses with tracellular and was not found secreted into the approximately 4 ug of E antigen pei dose). A extracellular medium. The antigen was pelleted second group of 10 mice was i'mmunized with at 100,000 x g for 1 hr. conditions which pellet an equivalent amount of crude membrane prointracellular membranes. This pelleted material. tein from baculovirus-infected S. frugiperda cells hereafter called the crude membrane prepara-that did not contain E antigen. A third group of tion, was resuspended in PBS and used to im-10 mice was immunized with heat-inactivated munize mice. DEN-i virus (four doses with an estimated I-10 ng of viral antien per dose). All mice were Immunogenicztv of the baculovirus-recombinant challenged at six Aeeks of age by ic injection of antigen in mice live DEN-I virus. The mice were followed for 28 days. be, ond which time no mortality due to The recombinant E antigen was tested for its virus infection was expected. Survival at each ability to stimulate antibodies against DEN-I vi-day post-challenge is shown in Figure 3 . In this rus in mice. One group of five three-week-old experiment, six of 10 recombinant-immunized BALB/c mice was immunized with a crude mice (P = 0.005). and five of 10 mice immunized membrane preparation from recombinant bac-with heat-inactivated DEN-I virus (P = 0.02) ulovirus-infected S. .rugiperda cells containing survived challenge. There were no survivors DEN-I E antigen (four doses with 4 ug of E an-among mice that did not receive E antigen. tigen per dose). Another group of five mice was
To determine if protection improved with inimmunized with heat-inactivated DEN-I virus creasing amounts of recombinant E antigen. % ival fromt the lowest to the highest dose tested Survival increased from two of 10 in the groups (11 =t0.0 1). When percent surN ival was plotted strains appear to be cross-neutralizable.
The finding that recombinant DEN-I E antias a function of antigen dose. a linear regression gen reacted with E-specific monoclonal antibodcoefficient (r) of 0.9 (P = 0.02) was obtained. iesand elicited virus-neutralizingantibody is sigindicating a positive correlation between antigen nificant for two reasons. First. it demonstrates dose and survival, that recombinant and authentic E proteins share common neutralization epitopes. Second. virus DISCUSSION neutralizing antibody has been found to correlate with protection against disease in a number of In the present study, a 1. 350 nucleotide DENprevious studies: mice immunized with a bac-I cDNA restriction fragment that encodes the ulovirus recombinant JE E protein made neufirst 415 amino acids or 83% of the complete E tralizing antibody and were protected against enprotein was expressed in a recombinant bacu-cephalitis."
4 Similarly, mice given vaccinia lovirus vector. Protein of the expected size. ap-expressing JE E antigen made neutralizing anproximately 48 kDM was produced. The recomtibodv and were strongly protected.-" binant protein was antigenic with DEN-I -specific, Passive administration of DEN-2 virus-neupolyclonal and monoclonal antibodies, and imtralizing monoclonal antibodies was observed to munogenic in BALB/c mice, in which it stimu-protect mice against lethal virus challenge.-lated the production of DEN-I virus-neutraliz-Conversely, a baculovirus recombinant DEN-I ing antibody. Immunized mice were significantly E antigen that was ineffective at eliciting neuprotected against lethal challenge with DEN-I tralizing antibody failed to protect mice (R. Putvirus.
nak, unpublished data). Instead ofcontaining 83% The DEN-I virus used in the neutralization of the E protein, as in the present construct. this and challenge experiments was a Western Pacific non-protective construct contained 100% of the isolate, Nauru Island 1974, the same as that used E protein. Recently, Men and others" 4 also reto make the cDNA expressed in baculovirus. Alported that vaccinia-DEN 4 recombinants. trunthough protection against other strains of DEN-cated at the carboxyl-terminus to synthesize ap-
